Innovent Biologics, Inc., a world-class biopharmaceutical company, together with AnHeart Therapeutics (AnHeart), a clinical-stage global biopharmaceutical company, jointly announced that the Center for Drug Evaluation (CDE) of China
Found this useful? Share it with your team.
